ArticleJournal of gastrointestinal oncology2014

Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial.

Sidra Anwar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.